Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy of bladder tumors : a systematic review and network meta-analysis

Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy of bladder tumors : a systematic review and network meta-analysis

Abstract Background Bacillus Calmette-Guerin (BCG) immunotherapy is the standard adjuvant treatment for high-risk, non-muscle invasive bladder cancer (NMIBC). However, BCG immunotherapy is commonly accompanied by significant lower urinary tract symptoms (LUTS) including symptoms such as urinary urge...

Full description

Saved in:
Bibliographic Details
Main Authors: Zihao Chen, Xin Chen, Dingchao Li, Jingang jian, Chang Yao, Xuedong Wei, Jianquan Hou
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Urology
Subjects:
BCG
Network meta-analysis
LUTS
Bladder cancer
Immunotherapy
Online Access:https://doi.org/10.1186/s12894-024-01675-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12894-024-01675-6

Similar Items